The metabolism of<unk>  has not been directly studied; in general antibodies are cleared principally by catabolism. The median clearance of<unk>  was 0.235 liters/day and the median half-life was 18 days.
Pertuzumab
Gatipotuzumab
Theralizumab
Caplacizumab
Elotuzumab
Idarucizumab
Risankizumab
Alemtuzumab